🇺🇸 Topical Antibiotic in United States

12 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Acne — 2 reports (16.67%)
  2. Retinal Detachment — 2 reports (16.67%)
  3. Application Site Burn — 1 report (8.33%)
  4. Chest Pain — 1 report (8.33%)
  5. Cough — 1 report (8.33%)
  6. Diarrhoea Haemorrhagic — 1 report (8.33%)
  7. Drug Ineffective — 1 report (8.33%)
  8. Intentional Product Misuse — 1 report (8.33%)
  9. Intraocular Pressure Increased — 1 report (8.33%)
  10. Nasopharyngitis — 1 report (8.33%)

Source database →

Topical Antibiotic in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Topical Antibiotic approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Topical Antibiotic in United States?

Hamilton Health Sciences Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.